Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House-Cleared Patent Reform Bill Is Likely Not The Final Word

This article was originally published in The Gray Sheet

Executive Summary

A sponsor of the House-passed patent reform bill indicated that a provision strongly opposed by device firms is likely to be revised before it becomes law

You may also be interested in...



PTO Lobbies Against Damages Award Provision In Patent Reform Bill

The Bush administration is actively lobbying the Senate Judiciary Committee to change a provision in pending patent reform legislation dealing with infringement damage awards

PTO Lobbies Against Damages Award Provision In Patent Reform Bill

The Bush administration is actively lobbying the Senate Judiciary Committee to change a provision in pending patent reform legislation dealing with infringement damage awards

Patent Bill Damages Provision Still Up For Debate – Senate Committee Report

A Senate Judiciary Committee 1report on a pending patent reform bill suggests a controversial provision on calculating infringement damages is still ripe for revision, but bill authors will not stray too far from their original intent

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025260

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel